Skip to main content
logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.130
-0.610 (-35.06%)
At close: Apr 2, 2026, 4:00 PM EDT
1.150
+0.020 (1.77%)
After-hours: Apr 2, 2026, 7:56 PM EDT

Inovio Pharmaceuticals Revenue

In the year 2025, Inovio Pharmaceuticals had annual revenue of $65.34K, down -69.99%.

Revenue (ttm)
$65.34K
Revenue Growth
-69.99%
P/S Ratio
1,194.83
Revenue / Employee
$583
Employees
112
Market Cap
78.07M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202565.34K-152.41K-69.99%
Dec 31, 2024217.76K-614.25K-73.83%
Dec 31, 2023832.01K-9.43M-91.89%
Dec 31, 202210.26M8.49M478.23%
Dec 31, 20211.77M-5.64M-76.05%
Dec 31, 20207.41M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Karyopharm Therapeutics146.07M
Agenus114.20M
Black Diamond Therapeutics70.00M
Innate Pharma10.57M
Alpha Cognition10.22M
Equillium4.39M
Cardiff Oncology593.00K
Revenue Rankings

INO News

More News